• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO AXIUM PRIME BRPL HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO AXIUM PRIME BRPL HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number APB-1-3-HX-ES
Device Problems Detachment of Device or Device Component (2907); Physical Resistance/Sticking (4012)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/09/2023
Event Type  malfunction  
Event Description
Medtronic received a report that two axium coils prematurely detached.The patient was undergoing surgery for treatment of an amorphous, unruptured aneurysm located in the right internal carotid artery with a max diameter of 5.1 mm and a 3.8 mm neck diameter.It was noted the patient's blood flow was normal and vessel tortuosity was moderate.It was reported that the patient underwent aneurysm embolization.The microcatheter was in place, and the coil (lot # 224889205) was detached prematurely when the coil was delivered.It was replaced without causing injury to the patient.It was reported coil separation/break/premature detachment occurred.It was noted the coil remains in the patient.The coil was not implanted in its intended location.It was reported the stent attached to the vessel wall in the parent artery.There was no surgical or medicinal intervention required.The pushwire was not bent or broken.There was no friction or difficulty during delivery.The physician did not reposition the coil.The physician did not attempt to detach the coil.It is unknown if the physician rotated the delivery pusher during the procedure.The continuous flush was administered during the procedure. it was reported the patient underwent aneurysm embolization.The microcatheter was in place, and the coil (lot # 225113020) was detached prematurely when the coil was delivered.It was replaced without causing injury to the patient.It was reported coil separation/break/premature detachment occurred.It was noted the coil remains in the patient.The coil was not implanted in its intended location.It was reported the procedure was stent assisted.There was no surgical or medicinal intervention required.The pushwire was not bent or broken.There was friction or difficulty during delivery.The physician did not reposition the coil.The physician did not attempt to detach the coil.The physician did not rotated the delivery pusher during the procedure.The continuous flush was administered during the procedure.The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).No patient symptoms or further complications were reported as a result of this event.Ancillary devices include a cook sheath, johnson and johnson guide catheter, echelon microcatheter, and sy-2 guidewire.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received that it was clarified both coils remain in the patient.Where in the internal carotid artery do the coil(s) remain is unknown.It was a problem with the product, as it didn't reach the lesion, and it was detached prematurely.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received a report that two axium coils prematurely detached.The patient was undergoing surgery for treatment of an amorphous, unruptured aneurysm located in the right internal carotid artery with a max diameter of 5.1 mm and a 3.8 mm neck diameter.It was noted the patient's blood flow was normal and vessel tortuosity was moderate.  it was reported that the patient underwent aneurysm embolization.The microcatheter was in place, and the coil  (lot # 224889205) was detached prematurely when the coil was delivered.It was replaced without causing injury to the patient.It was reported coil separation/break/premature detachment occurred.It was noted the coil remains in the patient.The coil was not implanted in its intended location.It was reported the stent attached to the vessel wall in the parent artery.There was no surgical or medicinal intervention required.The pushwire was not bent or broken.There was no friction or difficulty during delivery.The physician did not reposition the coil.The physician did not attempt to detach the coil.It is unknown if the physician rotated the delivery pusher during the procedure.The continuous flush was administered during the procedure.It was reported the patient underwent aneurysm embolization.The microcatheter was in place, and the coil (lot # 225113020) was detached prematurely when the coil was delivered.It was replaced without causing injury to the patient.It was reported coil separation/break/premature detachment occurred.It was noted the coil remains in the patient.The coil was not implanted in its intended location.It was reported the procedure was stent assisted.There was no surgical or medicinal intervention required.The pushwire was not bent or broken.There was friction or difficulty during delivery.The physician did not reposition the coil.The physician did not attempt to detach the coil.The physician did not rotated the delivery pusher during the procedure.The continuous flush was administered during the procedure.The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).No patient symptoms or further complications were reported as a result of this event.Ancillary devices include a cook sheath, johnson and johnson guide catheter, echelon microcatheter, and sy-2 guidewire.2023-06-12 e1 (rep, for, hcp): additional information received that to clarify the coils remain in the patient.It is unknown if there are future medicinal/surgical intervention planned to remove the coils.The anatomical location of the coils is the internal carotid artery.There are no procedural / post-procedural imaging (ct, angio, etc.) available.For axium coil (lot # 225113020) the resistance location is unknown.The coil came out of the introducer sheath smoothly.There was no kink/damage to the coil observed after removal.The echelon catheter lot number was b476715.
 
Manufacturer Narrative
H3: product analysis #(b)(4):equipment used: vis (m-78210), 203cm ruler (m-83361) as found condition (condition of returned device): one axium implant coil and one axium prime coil were returned for analysis within a shipping box; within a sealed plastic biohazard pouch and within dispenser tracks.The axium coils were returned without introducer sheaths.Visual inspection/damage location details: due to the condition in which the axium coils were returned, it could not be determined which pli or product event each axium coil corresponds to.(coil 1) the actuator interface, positive load indicator and coupler tube were found to be intact.This is indicative mechanical method detachment was not attempted.The axium coil pushwire was found to be kinked at 2.8cm and broken but retained by release wire at break indicator.This is indicative manual detachment was attempted.The coin was found to be pulled back from lumen stop and not returned.The implant coil was already detached and not returned.The shield coil was found to be broken.No other anomalies were observed.(coil 2) the actuator interface and coupler tube were found to be intact.This is indicative mechanical method detachment was not attempted.The axium coil pushwire was found to be broken but retained by release wire at load indicator.This is indicative manual detachment was attempted.The coin was found to be pulled back from lumen stop and not returned.The implant coil was already detached and not returned.The shield coil was found to be broken.No other anomalies were observed.Testing/analysis (including sem reports): (coil 1) under the microscope, the outer jacket was then removed.The lumen stop appeared to be visually acceptable.The retainer ring was found to be visually acceptable; however, unable to be measured accurately.(coil 2) under the microscope, the outer jacket was then removed.The lumen stop appeared to be visually acceptable.The retainer ring was found to be visually acceptable; however, unable to be measured accurately.Conclusion: based on the analysis performed, the customers report of ¿premature detachment¿ was confirmed as the axium coils was returned with the implant already detached and the cause could not be determined.Since the implant coil and included detach element were not returned for analysis, any contributing factors could not be determined.A possible cause for premature detachment is the coil not being retracted in a one-to-one motion with the implant pusher during repositioning.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM PRIME BRPL HLX
Type of Device
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX   22570
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key17097772
MDR Text Key316868558
Report Number9612164-2023-02494
Device Sequence Number1
Product Code KRD
UDI-Device Identifier00763000313807
UDI-Public00763000313807
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K151447
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAPB-1-3-HX-ES
Device Catalogue NumberAPB-1-3-HX-ES
Device Lot Number225113020
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/28/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age69 YR
-
-